GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Blau Farmaceutica BLAU3.SA · BRL

Health Care · B3 · 🇧🇷 Brazil

Compare

9.56

+0.84%

Close of 17 Nov 2026, in BRL

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Blau Farmaceutica — daily BMFBOVESPA:BLAU3

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Blau Farmaceutica on TradingView ↗
Market value
BRL 2.23bn
Last close × shares
Volume
288.4k
Shares, 17 Nov 2026
Price to earnings
6.8
Dividend yield
3.51%

About Blau Farmaceutica

Its shares trade on B3 under the ticker BLAU3.SA. It has been listed since 19 April 2021. In the fiscal year to 31 December 2025, it reported revenue of BRL 1.70bn and net income of BRL 295.0m. At that date it held total assets of BRL 3.64bn and shareholders' equity of BRL 2.27bn.

Blau Farmacêutica SA engages in manufacturing of pharmaceuticals. The company is headquartered in Cotia, Sao Paulo. The company went IPO on 2021-04-19. The firm focuses on the development, production and commercialization of medicines, which aim at treatment in the areas of oncology, nephrology, hematology and infectology, among others. Its product lines includes biopharmaceuticals, biosimilars, oncological - injectable, oncological - oral, blood products, antiviral and antiretrovirals, uterine stimulators, anaesthetics, antithrombotics, thrombolytics, female health care, antibiotics, non-beta lactams, cephalosporin, chloramphenicol, acid pumper inhibitor and other hospital products. The firm operates in Brazil, Argentina, Colombia, Peru, Uruguay, Chile and the United States, having a pharmaceutical industrial complex composed of five industrial plants, dedicated to the production of biological, biotechnological and oncological medicines, antibiotics, injectable anesthetics and biotechnological inputs.

Figures and description from our data supplier, not checked against the company's own report.

More about Blau Farmaceutica →

Latest on Blau Farmaceutica

Our reporting

We have not reported on Blau Farmaceutica yet.

Next results

23 Mar 2027

Due on 23 Mar 2027. Analysts expect earnings of 0.27 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Blau Farmaceutica's ticker?

Blau Farmaceutica trades as BLAU3.SA on B3, under ISIN BRBLAUACNOR8.

What was Blau Farmaceutica's last closing price?

9.56 on 17 Nov 2026. The figure is in BRL and is never converted.

When does Blau Farmaceutica next report results?

Results are expected on 10 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.